It's going to be very interesting to try and figure out after all this - is this company less or more risky.
Will we have solved the Africa risk for now?
Or does the Africa risk increase?
The market will likely overreact and oversell but unclear if it will be worth a buy.
Are we on budget and on schedule?
Will any of this matter when we are printing money in 6 months time?
I'll be holding cash and watching closely.
Ann: US$65m for 5% sale of Goulamina and Continued Suspension, page-22
Add LLL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $605.4M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| LLL (ASX) Chart |
Day chart unavailable